AI-generated summary
The authors report a triple-blinded, placebo-controlled randomised trial of whole-body photobiomodulation in 42 people with fibromyalgia, given over 12 sessions. They found significant reductions in pain and improvements in quality of life after 4 weeks, with some gains in kinesiophobia and self-efficacy, while pain catastrophising did not differ between groups. The authors state that more studies are needed to corroborate these findings.
- Participants
- 42
- Who or what was studied
- People with fibromyalgia recruited from a private care practice
- Limits stated in the abstract
- The authors state that more studies are needed to corroborate the findings, and the abstract does not report the wavelengths used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Fibromyalgia, Placebo-controlled, Trial registration. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.